- Home
- LZM vs PALI Comparison
LZM vs PALI Comparison
Compare LZM & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LZM | PALI |
|---|---|---|
| Founded | 2021 | 1996 |
| Country | Isle of Man | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 352.7M | 311.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LZM | PALI |
|---|---|---|
| Price | $5.20 | $1.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $7.00 | ★ $17.67 |
| AVG Volume (30 Days) | 275.7K | ★ 6.2M |
| Earning Date | 02-05-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $416,323.00 | N/A |
| Revenue This Year | $611.56 | N/A |
| Revenue Next Year | $445.45 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.90 | $0.53 |
| 52 Week High | $6.90 | $2.64 |
Technical Indicators
Market Signals| Indicator | LZM | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 73.43 | 45.91 |
| Support Level | $4.78 | $1.85 |
| Resistance Level | $5.14 | $2.12 |
| Average True Range (ATR) | 0.24 | 0.21 |
| MACD | 0.12 | -0.04 |
| Stochastic Oscillator | 95.89 | 21.99 |
Price Performance
Historical ComparisonAbout LZM Lifezone Metals Limited
Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining and to become an emerging supplier of responsibly sourced, lower-carbon and lower-sulfur dioxide emission metals to the battery, EV, and hydrogen markets modern pre-development exploration-stage metals company. Its business comprises three segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania and Intellectual property licensing comprises patents residing with and managed by the subsidiary and corporate.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.